Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Emily H. Jung
Assessing the Justification, Funding, Success, and Survival Outcomes of Randomized Noninferiority Trials of Cancer Drugs
JAMA network open
Medicine
Correction To: FDA and EMA Biosimilar Approvals
Journal of General Internal Medicine
Internal Medicine
Related publications
Negative Phase 3 Randomized Controlled Trials: Why Cancer Drugs Fail the Last Barrier?
International Journal of Cancer
Cancer Research
Oncology
Survival Time Outcomes in Randomized, Controlled Trials and Meta-Analyses: The Parallel Universes of Efficacy and Cost-Effectiveness
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
PCN163 Funding by SHAs for Rarer Cancers in England: Key Success Factors in the Uptake of Cancer Drugs Fund
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Clinical Outcomes and Survival of Advanced Renal Cancer Patients in Phase I Clinical Trials
Clinical Genitourinary Cancer
Oncology
Urology
Description of the Protocols for Randomized Controlled Trials on Cancer Drugs Conducted in Spain (1999–2003)
PLoS ONE
Multidisciplinary
Statistical Methods in Recent HIV Noninferiority Trials: Reanalysis of 11 Trials
PLoS ONE
Multidisciplinary
Assessing Variability and Uncertainty in Orthopedic Randomized Controlled Trials
Acta Orthopaedica
Medicine
Surgery
Orthopedics
Sports Medicine
Using Quality-Adjusted Progression-Free Survival as an Outcome Measure to Assess the Benefits of Cancer Drugs in Randomized-Controlled Trials: Case of the BOLERO-2 Trial
Breast Cancer Research and Treatment
Cancer Research
Oncology
Nutritional Interventions to Improve Clinical Outcomes in Ovarian Cancer: A Systematic Review of Randomized Controlled Trials
Nutrients
Nutrition
Food Science
Dietetics
